56 related articles for article (PubMed ID: 157807)
1. Clinical trial of weekly pyrazofurin.
Cummings FJ; Stoller RG; Calabresi P
Cancer Treat Rep; 1979 Aug; 63(8):1363-5. PubMed ID: 157807
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of pyrazofurin, alone and in combination with trifluorothymidine, in non-Hodgkin's lymphoma.
Warrell RP; Currie V; Kempin S; Young C
Cancer Treat Rep; 1979 Aug; 63(8):1423-5. PubMed ID: 113097
[TBL] [Abstract][Full Text] [Related]
3. Initial clinical study with pyrazofurin.
Ohnuma T; Holland JF
Cancer Treat Rep; 1977; 61(3):389-94. PubMed ID: 872139
[TBL] [Abstract][Full Text] [Related]
4. Phase I study of pyrazofurin in refractory acute myelogenous leukemia.
Vogler WR; Trulock PD
Cancer Treat Rep; 1978 Oct; 62(10):1569-71. PubMed ID: 152146
[TBL] [Abstract][Full Text] [Related]
5. Phase II evaluation of pyrazofurin in patients with carcinoma of the lung.
Gralla RJ; Currie VE; Wittes RE; Golbey RB; Young CW
Cancer Treat Rep; 1978 Mar; 62(3):451-2. PubMed ID: 348315
[No Abstract] [Full Text] [Related]
6. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
7. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of pyrazofurin in advanced head and neck cancer.
Cheng E; Currie V; Wittes RE
Cancer Treat Rep; 1979; 63(11-12):2047-8. PubMed ID: 526937
[No Abstract] [Full Text] [Related]
9. Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.
Carroll DS; Kemeny NE; Gralla RJ
Cancer Treat Rep; 1979 Jan; 63(1):139-40. PubMed ID: 369686
[No Abstract] [Full Text] [Related]
10. Treatment of refractory acute nonlymphocytic leukemia with a combination of pyrazofurin and cytarabine.
Kaplan HG; Appelbaum FR; Cheever MA; Greenberg PD; Wood T; Fefer A
Cancer Treat Rep; 1982 Jun; 66(6):1397-8. PubMed ID: 7083242
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy.
Nichols WC; Kvols LK; Ingle JN; Edmonson JH; Ahmann DL; Rubin J; O'Connell MJ
Cancer Treat Rep; 1978 May; 62(5):837-9. PubMed ID: 657166
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of pyrazofurin in advanced colorectal carcinoma.
Creagan ET; Rubin J; Moertel CG; Schutt AJ; O'connell MJ; Hahn RG; Reitemeir RJ; Frytak S
Cancer Treat Rep; 1977; 61(3):491-3. PubMed ID: 872147
[No Abstract] [Full Text] [Related]
13. [Phase I and pharmacokinetic study of SM-5887 by 5-day schedule].
Inoue K; Matsumura A; Horikoshi N; Aiba K; Mukaiyama T; Matsumura T; Ogihara A; Sumida T; Ogawa M
Gan To Kagaku Ryoho; 1992 Apr; 19(4):477-82. PubMed ID: 1558397
[TBL] [Abstract][Full Text] [Related]
14. Phase 2 study with Baker's Antifol in solid tumors.
Rodriguez V; Richman SP; Benjamin RS; Burgess MA; Murphy WK; Valdivieso M; Banner RL; Gutterman JU; Bodey GP; Freireich EJ
Cancer Res; 1977 Apr; 37(4):980-3. PubMed ID: 139205
[TBL] [Abstract][Full Text] [Related]
15. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
[TBL] [Abstract][Full Text] [Related]
17. A phase I study of pyrazofurin.
Salem PA; Bodey GP; Burgess MA; Murphy WK; Freireich EJ
Cancer; 1977 Dec; 40(6):2806-9. PubMed ID: 589556
[TBL] [Abstract][Full Text] [Related]
18. Phase I/II trial of weekly paclitaxel in patients with advanced lung cancer.
Akerley W
Semin Oncol; 1996 Dec; 23(6 Suppl 16):55-8. PubMed ID: 9007123
[TBL] [Abstract][Full Text] [Related]
19. [The clinical phase I study of TNP-351. The TNP-351 Research Committee].
Taguchi T; Niitani H; Furue H; Tsukagoshi S; Kanamaru R; Hasegawa K; Akazawa S; Yoneda S; Tominaga T; Sasaki T
Gan To Kagaku Ryoho; 1995 Feb; 22(2):259-71. PubMed ID: 7857102
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of oral topotecan in advanced non-small cell lung cancer.
White SC; Cheeseman S; Thatcher N; Anderson H; Carrington B; Hearn S; Ross G; Ranson M
Clin Cancer Res; 2000 Mar; 6(3):868-73. PubMed ID: 10741709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]